Search results for "indication"

showing 10 items of 114 documents

Indications and contraindications of dental implants in medically compromised patients: update.

2013

The aim of this study was to review the current scientific literature in order to analyse the indications and contraindications of dental implants in medically compromised patients. A reference research was carried out on PubMed using the key words “implant” AND (oral OR dental) AND (systemic disease OR medically compromised), in articles published between 1993 and 2013. The inclusion criteria were the following: clinical studies in which, at least, 10 patients were treated, consensus articles, reviewed articles and meta-analysis performed in humans treated with dental implants, and which included the disease diagnosis. A total of 64 articles were found, from which 16 met the inclusion crit…

medicine.medical_specialtySystemic diseaseOsteoporosisMEDLINEOdontologíaDiseaseReviewRisk FactorsmedicineEndocrine systemHumansDiseaseGeneral DentistryContraindicationDental Implantsbusiness.industryContraindications:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryCiencias de la saludSurgerystomatognathic diseasesOtorhinolaryngologyConcomitantUNESCO::CIENCIAS MÉDICASSurgeryImplantbusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence-a multi-centre study

2011

Abstract Introduction Bisphosphonates (BPs) are powerful drugs that inhibit bone metabolism. Adverse side effects are rare but potentially severe such as bisphosphonate-related osteonecrosis of the jaw (BRONJ). To date, research has primarily focused on the development and progression of BRONJ in cancer patients with bone metastasis, who have received high dosages of BPs intravenously. However, a potential dilemma may arise from a far larger cohort, namely the millions of osteoporosis patients on long-term oral BP therapy. Patients and methods This current study assessed 470 cases of BRONJ diagnosed between 2004 and 2008 at eleven different European clinical centres and has resulted in the …

medicine.medical_specialtyTime FactorsSettore MED/09 - Medicina Internamedicine.medical_treatmentOral Surgical ProceduresOsteoporosisAdministration OralSettore MED/28 - Malattie OdontostomatologicheInternal medicinemedicineHumansMedical historyAdverse effectBone Density Conservation AgentsDiphosphonatesDose-Response Relationship Drugbusiness.industryContraindicationsOsteonecrosisBisphosphonatemedicine.diseaseSurgeryZoledronic acidOtorhinolaryngologyCohortOral and maxillofacial surgeryOsteoporosisSurgeryOral Surgeryosteoporosis bisphosphonates ostenecrosis jawsOsteonecrosis of the jawbusinessJaw Diseasesmedicine.drug
researchProduct

Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study

2005

Summary. Background: Retrievable inferior vena cava (IVC) filters offer the attractive possibility to be definitive or to be removed when they become unnecessary. Objective: The purpose of this study was to evaluate the efficacy and the likelihood to remove the retrievable IVC filter ALN. Methods: A total of 30 patients (13 males and 17 females, mean age 57 ± 15 years) underwent placement of ALN filters. Indications for implantation were acute venous thromboembolism (VTE) with a contraindication to anticoagulation in 26 cases (86%), primary prophylaxis after major trauma in two cases (7%) or before surgery in two patients with very high thromboembolic risk (7%). Results: The filter was succ…

medicine.medical_specialtyVena cava filtersbusiness.industryDeep veinRetrievable inferior vena cava filterHematologymedicine.diseaseThrombosisAsymptomaticInferior vena cavaSurgerymedicine.anatomical_structuremedicine.veinVena cava interruptionMedicineObservational studyRadiologymedicine.symptombusinessContraindicationVenous thromboembolismVenous thromboembolismJournal of Thrombosis and Haemostasis
researchProduct

Clinical update: bariatric surgery.

2007

medicine.medical_specialtybusiness.industryGeneral surgeryContraindicationsMEDLINEGastric BypassBariatric SurgeryGeneral Medicinemedicine.diseaseObesityBody Mass IndexObesity MorbidText miningWeight lossWeight LossmedicineHumansLaparoscopymedicine.symptombusinessBody mass indexLancet (London, England)
researchProduct

EP755 Laparoscopically modified laterally extended endopelvic resection for gynecological malignancies involving pelvic side wall: a feasibility anal…

2019

Introduction/Background Lateral pelvic side wall involvement by gynecological malignancies has been considered for a long time an absolute contraindication to curative resection. Recently the surgical paradigm is challenged with the development of the Laterally Extended Endopelvic Resection, LEER. Although the LEER is perfectly standardized in open surgery, just one small experience has been published about its endoscopic feasibility.The objective of this study is to analyze the feasibility of Laparoscopically Modified Laterally Extended Endopelvic Resection, LM-LEER, in patients with gynecological malignancies involving the lateral pelvic side wall. Methodology We retrospectively evaluated…

medicine.medical_specialtybusiness.industryOpen surgeryGynecological cancerResectionSurgeryBlood lossmedicineOperative timeIn patientHemoperitoneummedicine.symptombusinessContraindicationePoster
researchProduct

Surgery vs. chemotherapy for ovarian cancer recurrence: what is the best treatment option

2020

Nowadays, the best treatment option for ovarian cancer recurrence is often subjective, can vary in the different centers and depend on personal experience. Arbeitsgemeinschaft Gynaekologische Onkologie (AGO)-DESKTOP studies have identified a population of patients who could benefit from secondary surgery. The results of the Gynecologic Oncology Group (GOG)-0213 study were recently published, which showed no advantage in terms of overall survival (OS) in patients with platinum-sensitive recurrent epithelial ovarian undergoing secondary cytoreductive surgery (SCS) compared to chemotherapy alone. Aim of this narrative review is to summarize the best aspects that can make ovarian cancer recurre…

medicine.medical_specialtyeducation.field_of_studyChemotherapyendocrine system diseasesPerformance statusbusiness.industrymedicine.medical_treatmentPopulationTreatment optionsGynecologic oncologymedicine.diseaseSurgery03 medical and health sciences0302 clinical medicineRecurrent Ovarian Cancer030220 oncology & carcinogenesismedicineSurgery030212 general & internal medicineOvarian cancereducationbusinessContraindicationGland Surgery
researchProduct

Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?

2021

International journal of environmental research and public health : IJERPH 18(8), 4344 (2021). doi:10.3390/ijerph18084344

medicine.medical_specialtymasksHealth Toxicology and MutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Respiratory impairmentPopulationcontraindicationsReviewRespiratory physiologyNoseAudiology03 medical and health sciences0302 clinical medicinesurgical maskmedicineHumansddc:610030212 general & internal medicineeducationPersonal protective equipmentN95 face maskNoseriskphysical exertionMoutheducation.field_of_studySARS-CoV-2hypoxiabusiness.industryRPublic Health Environmental and Occupational HealthCOVID-19MIES syndromehypercapniadyspneaSurgical maskmedicine.anatomical_structurepersonal protective equipmentadverse effectslong-term adverse effectshealth risk assessmentMedicineLong Term Adverse Effectsbusinessheadache030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

Effects of mandibular advancement surgery on the temporomandibular joint and muscular and articular adaptive changes--a systematic review.

2016

The objective of this study was to assess the anatomical changes to the condyle and articular disc following mandibular advancement surgery, the adaptation of the masticatory muscles, and the improvement or worsening of temporomandibular disorders (TMD) in patients with pre-existing disorders and those who developed them following surgery. Four databases were searched systematically: PubMed, Scopus, Embase, and Cochrane Library. Of the 544 articles initially selected, 219 were duplicates and a further 165 were excluded on the basis of their titles and abstracts. On reading the full text, 89 were excluded because they were of no interest and 43 because they did not meet the inclusion criteri…

medicine.medical_specialtymedicine.medical_treatmentOrthognathic surgeryDentistryCochrane LibraryCondyleCondylar resorption03 medical and health sciences0302 clinical medicinestomatognathic systemTemporomandibular Joint DiscMedicineHumans030212 general & internal medicineBone ResorptionContraindicationOrthodonticsbusiness.industryTemporomandibular Joint DiscMandibular Condyle030206 dentistryTemporomandibular Joint Disordersmedicine.diseaseAdaptation PhysiologicalMasticatory forceTemporomandibular jointSurgerystomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyMasticatory MusclesSurgeryOral SurgerybusinessMandibular AdvancementInternational journal of oral and maxillofacial surgery
researchProduct

Pancreatoduodenectomy with artery-first approach.

2019

"Artery-first approach" encompasses different aspects for the surgical treatment of pancreatic cancer. It is a surgical technique or set of techniques which share in common the dissection of the main arterial vasculature involved in pancreatic cancer, before any irreversible surgical step is performed. On the other hand it represents the need for a meticulous dissection of the arterial planes and clearing of the retropancreatic tissue between the superior mesenteric artery, the common hepatic artery and portal vein in an attempt to achieve R0 resections. The recent expansion of this approach is based mainly on three factors: venous involvement should not be considered a contraindication for…

medicine.medical_specialtymedicine.medical_treatmentPortal veinDissection (medical)PancreaticoduodenectomyContraindications Procedure03 medical and health sciences0302 clinical medicineHepatic ArteryMesenteric Artery Superiormedicine.arteryPancreatic cancermedicineHumansNeoplasm InvasivenessSuperior mesenteric arteryContraindicationPancreasCommon hepatic arterybusiness.industryPortal VeinMargins of ExcisionPancreatic Diseasesmedicine.diseasePancreaticoduodenectomyPrognosisPancreatic Neoplasmsmedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgeryRadiologybusinessArteryMinerva chirurgica
researchProduct

Could isotretinoin be a protective agent against COVID-19?: A dermatologist perspective.

2021

Being a "trending" unique treatment for moderate-to-severe acne, isotretinoin (13-cis retinoic acid) (ISO) is currently considered by experts the first line treatment even for mild acne, unless there is an absolute contraindication. ISO was identified, among other retinoids, to inhibit SARS-CoV-2 replication in Vero E6 cells. Shoemark et al.1.

medicine.medical_specialtyskinCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Retinoic acidDermatologyProtective Agents030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCOVID‐19Acne VulgarismedicineHumansskin and connective tissue diseasesLetters to the EditorIsotretinoinContraindicationAcnebusiness.industrySARS-CoV-2COVID-19isotretinoinmedicine.diseaseDermatologyFirst line treatmentchemistry030220 oncology & carcinogenesisVero cellbusinessmedicine.drugDermatologistsJournal of cosmetic dermatology
researchProduct